Company intelligence / Profile preview

Sydney Angels

Sydney, New South Wales, Australia
Ownership
Private
Development stage
Phase 3
01

Overview

Sydney Angels is one of Australia’s oldest and most active angel investor groups, established in 2008. It has over 100 members who collectively invest in early-stage Australian startups across diverse sectors—including biotechnology and medical devices—via direct syndicates and the $10M Sydney Angels Sidecar Fund. The group has invested over AUD $41 million into more than 90 startups, which have subsequently raised over $780 million in follow-on funding. Notable exits include Atomo Diagnostics (ASX IPO), Clarity Pharmaceuticals (ASX IPO), Instaclustr (acquired by NetApp), and Aurtra (acquired by Schneider Electric). Members benefit from structured deal screening cycles, collaborative due diligence, and access to high-growth opportunities selected from hundreds of annual applicants

Industry
Investors
02

Drug pipeline

4 assets

67Cu-SAR-bisPSMA

Phase 3
Indications
Prostate cancer

3 more assets in the full pipeline.

Request access →
03

Partnerships

Collaborates with other Australian angel groups such as Brisbane Angels, Melbourne Angels, Southern Angels, Capital Angels, Hunter Angels, Perth Angels for co-investment opportunities

Beyond the preview

Go deeper on Sydney Angels.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sydney Angels.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call